Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bcp30643
Molecular Weight | 233.55 g/mol |
---|---|
Molecular Formula | Fe3H2O4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | 233.800115 g/mol |
Monoisotopic Mass | 233.800115 g/mol |
Topological Polar Surface Area | 74.6 Ų |
Heavy Atom Count | 7 |
Formal Charge | 0 |
Complexity | 10.3 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Feraheme |
PubMed Health | Parenteral Mineral/Trace Mineral Combination (Injection) |
Drug Classes | Anticonvulsant, Laxative, Hyperosmotic, Nutritive Agent, Parenteral Mineral-Trace Mineral, Renal-Urologic Agent |
Drug Label | Feraheme, an iron replacement product, is a non-stoichiometric magnetite (superparamagnetic iron oxide) coated with polyglucose sorbitol carboxymethylether. The overall colloidal particle size is 17-31 nm in diameter. The chemical formula of Feraheme... |
Active Ingredient | Ferumoxytol |
Dosage Form | Solution |
Route | Intravenous |
Strength | eq 510mg iron/17ml (eq 30mg iron/ml) |
Market Status | Prescription |
Company | Amag Pharms |
2 of 2 | |
---|---|
Drug Name | Feraheme |
PubMed Health | Parenteral Mineral/Trace Mineral Combination (Injection) |
Drug Classes | Anticonvulsant, Laxative, Hyperosmotic, Nutritive Agent, Parenteral Mineral-Trace Mineral, Renal-Urologic Agent |
Drug Label | Feraheme, an iron replacement product, is a non-stoichiometric magnetite (superparamagnetic iron oxide) coated with polyglucose sorbitol carboxymethylether. The overall colloidal particle size is 17-31 nm in diameter. The chemical formula of Feraheme... |
Active Ingredient | Ferumoxytol |
Dosage Form | Solution |
Route | Intravenous |
Strength | eq 510mg iron/17ml (eq 30mg iron/ml) |
Market Status | Prescription |
Company | Amag Pharms |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
The acquisition adds AMAG's key products Feraheme®, Makena® and Ciraparantag to Covis' pipeline as it carries out its mission of expanding patient access to much needed therapies.
Lead Product(s): Ferumoxytol
Therapeutic Area: Hematology Brand Name: Feraheme
Study Phase: Approved FDFProduct Type: Vitamins/Minerals/Inorganic Salts
Sponsor: Covis Pharma
Deal Size: $647.0 million Upfront Cash: $647.0 million
Deal Type: Acquisition November 16, 2020
Lead Product(s) : Ferumoxytol
Therapeutic Area : Hematology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Covis Pharma
Deal Size : $647.0 million
Deal Type : Acquisition
Covis Group Completes Acquisition of AMAG Pharmaceuticals
Details : The acquisition adds AMAG's key products Feraheme®, Makena® and Ciraparantag to Covis' pipeline as it carries out its mission of expanding patient access to much needed therapies.
Product Name : Feraheme
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : $647.0 million
November 16, 2020
Details:
With this deal, Covis gains access to AMAG’s two commercial therapies, Makena, indicated for women with risk of preterm birth in singleton pregnancies and Feraheme indicated treat iron deficiency anaemia in CKD patients and for whom oral iron is not suitable or ineffective.
Lead Product(s): Ferumoxytol
Therapeutic Area: Hematology Brand Name: Feraheme
Study Phase: Approved FDFProduct Type: Vitamins/Minerals/Inorganic Salts
Sponsor: Covis Pharma
Deal Size: $647.0 million Upfront Cash: $647.0 million
Deal Type: Acquisition January 10, 2020
Lead Product(s) : Ferumoxytol
Therapeutic Area : Hematology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Covis Pharma
Deal Size : $647.0 million
Deal Type : Acquisition
Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals
Details : With this deal, Covis gains access to AMAG’s two commercial therapies, Makena, indicated for women with risk of preterm birth in singleton pregnancies and Feraheme indicated treat iron deficiency anaemia in CKD patients and for whom oral iron is not su...
Product Name : Feraheme
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : $647.0 million
January 10, 2020
Global Sales Information
Market Place
ABOUT THIS PAGE
86
PharmaCompass offers a list of Ferumoxytol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ferumoxytol manufacturer or Ferumoxytol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ferumoxytol manufacturer or Ferumoxytol supplier.
PharmaCompass also assists you with knowing the Ferumoxytol API Price utilized in the formulation of products. Ferumoxytol API Price is not always fixed or binding as the Ferumoxytol Price is obtained through a variety of data sources. The Ferumoxytol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cytogen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cytogen, including repackagers and relabelers. The FDA regulates Cytogen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cytogen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cytogen manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cytogen supplier is an individual or a company that provides Cytogen active pharmaceutical ingredient (API) or Cytogen finished formulations upon request. The Cytogen suppliers may include Cytogen API manufacturers, exporters, distributors and traders.
click here to find a list of Cytogen suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cytogen DMF (Drug Master File) is a document detailing the whole manufacturing process of Cytogen active pharmaceutical ingredient (API) in detail. Different forms of Cytogen DMFs exist exist since differing nations have different regulations, such as Cytogen USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cytogen DMF submitted to regulatory agencies in the US is known as a USDMF. Cytogen USDMF includes data on Cytogen's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cytogen USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cytogen suppliers with USDMF on PharmaCompass.
Cytogen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cytogen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cytogen GMP manufacturer or Cytogen GMP API supplier for your needs.
A Cytogen CoA (Certificate of Analysis) is a formal document that attests to Cytogen's compliance with Cytogen specifications and serves as a tool for batch-level quality control.
Cytogen CoA mostly includes findings from lab analyses of a specific batch. For each Cytogen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cytogen may be tested according to a variety of international standards, such as European Pharmacopoeia (Cytogen EP), Cytogen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cytogen USP).